首页> 外文会议>Proceedings of the 31st annual conference of the North American Thermal Analysis Society(NATAS) >Thermal Characterization Of The Amorphous Form Of Sulfapyridine-The Effect Of Humidity And Excipients
【24h】

Thermal Characterization Of The Amorphous Form Of Sulfapyridine-The Effect Of Humidity And Excipients

机译:磺胺吡啶的非晶形的热表征-湿度和赋形剂的影响

获取原文
获取原文并翻译 | 示例

摘要

Sulfapyridine has been reported to exist in five polymorphic forms and one amorphousrnform. The high enthalpy and entropy properties of the amorphous form would result in enhancedrnsolubility of the amorphous form and therefore greater bioavailability. Differential ScanningrnCalorimetry (DSC) and Powder X-Ray Diffraction (PXRD) were extensively used throughoutrnthe study. This study was an effort to determine a protocol for the conversion of the crystallinern(commercial variety) to the amorphous form and then study the stability of the amorphous formrnwith common pharmaceutical excipients - microcrystalline cellulose (MCC) and magnesiumrnstearate (MgSt) at 10, 40 and 100% relative humidity (RH) conditions for a period of 20 days.rnAll DSC studies were carried out at a heating rate of 10℃/min with a nitrogen flow rate of 50rnmL/min. The amorphous form had a glass transition temperature between 55-60℃, a coldrncrystallization peak between 92-99℃, melting of the metastable form between 185-189℃rnfollowed by melting of the stable form between 191-193℃. The study revealed that thernamorphous form undergoes transition to the crystalline form at 100 and 40% relative humidityrnconditions but was stable at 10% relative humidity conditions for a 20 day exposure period. Thernamorphous form did not absorb any water under different humidity conditions suggesting thatrnthe presence of water alone, at >10 % relative humidity causes it to onvert from amorphous torncrystalline form. The excipients had no or little interaction with the drug and also had nornstabilizing action on the amorphous form.
机译:据报道,磺胺吡啶以五种多晶型形式和一种无定形形式存在。无定形形式的高焓和熵性质将导致无定形形式的溶解度增强,因此具有更高的生物利用度。在整个研究过程中,差示扫描量热法(DSC)和粉末X射线衍射(PXRD)被广泛使用。这项研究旨在确定将结晶(商业品种)转化为无定形形式的方案,然后研究常见药用赋形剂–微晶纤维素(MCC)和硬脂酸镁(MgSt)在10、40时的无定形形式的稳定性。在100%相对湿度(RH)条件下进行20天。rn所有DSC研究均在10℃/ min的升温速率和50rnmL / min的氮气流速下进行。无定形形式的玻璃化转变温度在55-60℃之间,冷结晶峰在92-99℃之间,亚稳形式的熔化在185-189℃之间,随后稳定形式的熔化在191-193℃之间。研究表明,在100%和40%的相对湿度条件下,热晶型转变为晶型,但在20%的暴露时间内,在10%的相对湿度条件下稳定。在不同的湿度条件下,热晶型不会吸收任何水分,这表明在相对湿度> 10%的情况下,单独存在水会使水从无定形的晶型转变。赋形剂与药物没有相互作用或几乎没有相互作用,并且对无定形形式也具有稳定作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号